US Stock MarketDetailed Quotes

IPHA Innate Pharma

Watchlist

1.990
-0.100-4.78%

Close Mar 4 16:00 ET

2.002
+0.012+0.60%

Post 19:39 ET

166.79MMarket Cap-4.46P/E (TTM)

Innate Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Innate Pharma FY2024 Estimates Date

Currency：USDMar 27, 2025

	Estimate	YoY
Revenue	57.19M	-15.93%
EPS	-0.55	-465.78%

Analyst Rating

Strong Buy

Feb 28, 2025

Innate Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
Mar 10, 2020	2019/Q4	13.330M / 22.402M	--
--	2019/Q3	13.330M / 24.747M	--
Sep 13, 2019	2019/Q2	29.580M / 43.206M	--
--	2019/Q1	-- / 43.206M	--

DatePeriodRevenue/EstimateEarnings Call

Mar 10, 20202019/Q413.330M / 22.402M--

--2019/Q313.330M / 24.747M--

Sep 13, 20192019/Q229.580M / 43.206M--

--2019/Q1-- / 43.206M--

--------

Unlock Free Earnings Estimates

Open Account

Innate Pharma Earnings Reports

6-K: Report of foreign private issuer (related to financial reporting)

Nov 20, 2024 06:07 ET

6-K: Report of foreign private issuer (related to financial reporting)

Nov 13, 2024 06:08 ET

6-K: Report of foreign private issuer (related to financial reporting)

Sep 12, 2024 06:19 ET

6-K: Report of foreign private issuer (related to financial reporting)

Sep 12, 2024 06:09 ET

Trending Stocks

Symbol Mini Chart % Chg

DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS

DMZPY

+2.22%

Unlock the Full List

Analysis

Analyst Rating

Updated: Feb 28, 2025

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data